About this market
The prevalence of several neurological disorder is increasing across the world. The probability of diseases such as AD, PD, UI, fecal incontinence, epilepsy, dementia, and movement disorders increases significantly with age. Hence the prevalence of neurological disorders increases due to the growth of the aging population. other risk factors associated with neurological disorders such as high blood pressures (BP), obesity and the consumption of alcohol and tobacco are also increasing. Therefore, the rising prevalence of neurological disorders drives the growth of the market. analysts have predicted that the neurostimulation devices market will register a CAGR of almost 11% by 2022.
Market Overview
Rising prevalence of neurological disorders
The increasing prevalence of several neurological disorders is increasingly, globally. Therefore, the aging population will positively affect the prevalence of neurological disorders.
High cost of neurostimulation devices and procedures
The high cost of neurostimulation devices limits their adoption in several developing countries. The availability of information about the cost of neurostimulation devices is limited. Therefore, gathering data about the high cost of neurostimulation devices is s complex task.
For the detailed list of factors that will drive and challenge the growth of the neurostimulation devices market during the 2018-2022, view our report.
Competitive Landscape
The neurostimulation devices market is concentrated. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’